Search

everythinglearnresearchcommunity

for

Search:↓

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Canakinumab's effect on COVID-19 outcomes is unclear.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

595 nm pulsed dye laser is a cost-effective treatment for nonmelanoma skin cancer with a low recurrence rate.

Breezula® may be more effective than Minoxidil in promoting hair growth by reducing a hair growth inhibitor.

A man had a non-cancerous, fast-growing skin lump on his arm that was removed with surgery.

Platelet Rich Plasma reduces psoriasis symptoms but isn't enough alone for treatment.

Placenta polypeptide injection is a safe and effective treatment for sensitive skin.

COVID-19 vaccines can cause minor skin reactions, including those related to Bullous Pemphigoid, but these usually resolve on their own.

COVID-19 infection rates were low in patients with immune diseases, regardless of their treatment type.

Ritlecitinib works well and is safe for treating alopecia areata.

Imiquimod shows promise as a non-invasive treatment for certain HPV-related lesions, but more research is needed to optimize its use.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

New therapies like JAK inhibitors and stem cells show promise in treating vitiligo.

An automated system can predict death risk in thin melanoma by analyzing immune cells.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Finasteride and dutasteride might lower melanoma risk.

MSC-CM cream speeds up burn wound healing better than the control treatment.

Infliximab can cause SAPHO syndrome, which may improve with Spesolimab and methotrexate.

Pioglitazone, Trimipramine, and Dimetindene may be repurposed to treat psoriasis.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.